Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase I/II Xerecept results promising in children with cerebral tumors

May 23, 2012

French researchers present new HSP 90 inhibitors

May 23, 2012

Cellceutix gives update on IND for novel p53 anticancer drug

May 22, 2012

Medivation submits NDA for enzalutamide

May 22, 2012

Phase III MISSION trial misses primary endpoint

May 22, 2012

Daiichi Sankyo and the Japanese National Cancer Center enter anticancer collaboration

May 22, 2012

Peregrine Pharmaceuticals reports data from phase IIb study in NSCLC

May 22, 2012

Kinex out-licenses rights to KX-02 in greater China territory

May 22, 2012

DPT-NX7 induces regressions in squamous cell carcinoma model

May 22, 2012

Merck KGaA discloses new PI3K inhibitors

May 22, 2012

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...